Patient Access Articles & Analysis

In the Headstart Programme, EIT Health decided to support 89 healthcare start-ups in Europe, including 17 teams from more progressing regions. Seven start-ups come from Italy, two from Portugal, Poland, and Estonia and one from Greece, Romania, Hungary, and Latvia. All the teams get €40 000 to develop their innovations and entice private investment. Start-ups will compete for an additional ...

By Longenesis

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the launch of its Patient Therapy Access Program (“PTAP”), which will provide qualifying patients access to on-label Portable Neuromodulation Stimulator (“PoNS”) Therapy at a significantly reduced price. ...

By Helius Medical Technologies, Inc.

TOPIC: Leanness and the Culture of Improvement Plenary Session 2 at Healthcare Management Forum: Process Improvement and Operational Excellence WHEN: Monday, April 4 2011 at 10:00 a.m WHERE: Toronto Priority Code: 3BL1 Featuring: Matthew Anderson, President and Chief Executive Officer, William Osler Health System Robert S. Bell, President and Chief Executive Officer, University Health Network ...

By 3BL Media

Isabel Healthcare and Riverwood Healthcare have partnered to integrate Isabel’s AI symptom checker / self-triage platform into the Riverwood website to enhance care access and patient engagement. The symptom checker has been customized for Riverwood with integration of live chat and care option selection links and other pertinent content to help patients navigate to Riverwood care services ...

By Isabel Healthcare

CrossBay Medical, Inc., a health technology company focused on humanizing the delivery of women’s healthcare, has announced the launch of a new website, introducing its CrossGlide™ technology platform. The site, www.crossbaymedicalinc.com features animation and videos unveiling the CrossGlide concept and how it works to enhance and improve the patient experience for cervical access ...

By CrossBay Medical

The Centers for Medicaid and Medicare (CMS) announced the establishment of the MCIT (Medicare Coverage of Innovative Technology) pathway, which is designed to provide coverage and access to new, innovative medical devices and diagnostics which have received FDA Breakthrough Device Designation to Medicare beneficiaries nationwide. Through this pathway, Breakthrough devices will automatically be ...

By ImCare Biotech, LLC

Dr. Michelle McMurry-Heath, the president and CEO of the Biotechnology Innovation Organization (BIO), released a statement today warning that an executive order to adopt foreign price controls on certain prescription medicines could “cripple” companies working to eradicate COVID-19 and lead to less patient access to lifesaving treatments. Dr. McMurry-Heath raised these and other ...

By Biotechnology Industry Organization (BIO)

CMR Surgical – the global medical device company headquartered in Cambridge, UK – has announced the installation of its first Versius system in Rome, at the Cristo Re Hospital. Cristo Re is part of the renowned GIOMI Group and is the first of the leading group of private clinics in Italy to install this practical and innovative surgical tool. Versius is being used as part of a ...

By CMR Surgical Ltd

Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Court of Appeals for the Federal Circuit (USCAFC) has upheld the U.S. Patent and Trademark Appeal Board’s decisions for unpatentability of five device patents for Sanofi’s Lantus® SoloSTAR®, as well as a district court decision on one of these patents. The Patent ...

By Biocon

Signifier Medical Technologies LLC, a Boston-based medical technology company, announced today that the Centers for Medicare & Medicaid Services (CMS) established two new Level II Healthcare Common Procedure Coding System (HCPCS) codes to describe eXciteOSA, the first-ever FDA authorized de-novo device for daytime treatment of mild obstructive sleep apnea (OSA) and primary snoring. The CMS ...

By Signifier Medical Technologies Ltd

Mercury Biomed announces that the United States Patent and Trademark Office (USPTO), after substantive examination, has issued its patent application entitled, “Altering Temperature in a Mammalian Body ” (U.S. Patent No. 9,549,844). The 844 patent, having a September 2009 priority date and exclusively licensed from the University of Texas at Austin, further expands Mercury’s ...

By Mercury Biomed

MeMed, a leader in host response technologies, today announces a $93 million private financing round, bringing total funding in the Company to over $200 million, including support from the U.S. Department of Defense and EU Commission. Funds will be used to scale up manufacturing, accelerate commercialization and expand MeMed’s pioneering host immune response product portfolio. ...

By MeMed

On July 15, 2021, The openning ceremony of a new state of the art peptide manufacture facility was held in Jintang, Chengdu. The successful completion of the facility marks the successful industrialization of Aikening® in Jintang. Aiming at intelligent manufacturing, high efficiency and eco system, and a quality system to be certified by the US FDA, EU EMA and China NMPA, the peptide ...

By Frontier Biotechnologies Inc.

A complete redesign of the T-Stat was launched in 2020. New features included a sleek and strong exterior of powder coated metal, framed with a soft plastic bumper to prevent any damage in the hospital environment. Battery back-up was added to make patient ambulation and transfer seemless and without any interruption in patient data. WiFi access has been added to accommodate hospitals and labs ...

By Spectros Medical Devices Inc.

Dublin – Ireland, 29 June 2021 – Mainstay Medical Holdings plc (the “Company”) today announced the limited commercial launch in the U.S. of ReActiv8, its implantable Restorative Neurostimulation™ system to treat intractable chronic low back pain. The ReActiv8 system will be available in the U.S. through ReActiv8-certified physicians commencing in the summer of ...

By Mainstay Medical

The University of California San Francisco (UCSF) Health Hub has selected CardioWise, Inc. a Digital Health Awards 1st Round (Top Ten) Finalist in its Best Cardiovascular Digital Diagnostic category. The goal of UCSF Digital Health Awards was to select companies that promote faster, better, more cost-effective healthcare by improving outcomes such as shorter hospital stays, reduced patient and ...

By CardioWise Inc.

GRAIL, LLC, a healthcare company whose mission is to detect cancer early, today announced a collaboration with the Knight Cancer Institute at Oregon Health & Science University (OHSU) to offer Galleri®, GRAIL’s multi-cancer early detection (MCED) blood test. OHSU will provide patients access to Galleri via a pilot program to help find signals of cancer in earlier stages and advance ...

By Grail, Inc.

TOPIC: Engaging Doctors and Nurses in Process Changes with the Vital Hub Internet Phone Application Plenary Session 7 Healthcare Management Forum: Process Improvement and Operational Excellence WHEN: Tuesday, April 5 2011 at 9:00 a.m WHERE: Toronto Priority Code: 3BL1 Featuring: Neil Closner, Vice-President, Business Development, Mount Sinai Hospital Mount Sinai Hospital developed an in house ...

By 3BL Media

Alleviant Medical Inc., a privately-held medical device company, today announced that the US Food and Drug Administration (FDA) has granted the company a Breakthrough Device designation for its transcatheter technology. The technology offers a no-implant interatrial shunt therapy for patients suffering from heart failure with preserved (HFpEF) and mid-range ejection fraction (HFmrEF) who remain ...

By Alleviant Medical, Inc.

This agreement will bring new business to the biotech company, which is expanding its manufacturing capabilities and maintains its identity, brand, and complete team The transaction validates mAbxience differentiated core competencies in the development, manufacturing and commercialization of biopharmaceutical products With this strategic transaction the Spanish group Insud will also have ...

By mAbxience